NKTR vs. PGY

Last updated Apr 2, 2026

Compare and contrast key facts about Nektar Therapeutics (NKTR) and Pagaya Technologies Ltd. (PGY).

Performance

NKTR vs. PGY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nektar Therapeutics (NKTR) and Pagaya Technologies Ltd. (PGY). The values are adjusted to include any dividend payments, if applicable.

NKTR vs. PGY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
NKTR Nektar Therapeutics	79.07%	203.08%	64.60%	-75.00%	-45.67%
PGY Pagaya Technologies Ltd.	-44.02%	124.97%	-43.90%	11.29%	-79.61%

Fundamentals

Market Cap NKTR : $1.54B PGY : $1.19B
EPS NKTR : -$10.15 PGY : $0.90
PS Ratio NKTR : 22.15 PGY : 0.84
PB Ratio NKTR : 17.11 PGY : 2.48
Total Revenue (TTM) NKTR : $55.23M PGY : $1.26B
Gross Profit (TTM) NKTR : $55.04M PGY : $512.17M
EBITDA (TTM) NKTR : -$122.97M PGY : $192.27M

Returns By Period

In the year-to-date period, NKTR achieves a 79.07% return, which is significantly higher than PGY's -44.02% return.

NKTR

• 1D: 5.23%
• 1M: 10.75%
• YTD: 79.07%
• 6M: 28.65%
• 1Y: 691.99%
• 3Y*: 92.93%
• 5Y*: -24.37%
• 10Y*: -9.98%

PGY

• 1D: 0.43%
• 1M: 3.17%
• YTD: -44.02%
• 6M: -60.88%
• 1Y: 10.80%
• 3Y*: -1.49%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NKTR vs. PGY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NKTR

NKTR Risk / Return Rank: 99
NKTR Sharpe Ratio Rank: 98
NKTR Sortino Ratio Rank: 99
NKTR Omega Ratio Rank: 98
NKTR Calmar Ratio Rank: 99
NKTR Martin Ratio Rank: 99

PGY

PGY Risk / Return Rank: 46
PGY Sharpe Ratio Rank: 45
PGY Sortino Ratio Rank: 50
PGY Omega Ratio Rank: 48
PGY Calmar Ratio Rank: 44
PGY Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NKTR vs. PGY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nektar Therapeutics (NKTR) and Pagaya Technologies Ltd. (PGY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NKTR	PGY	Difference
Sharpe ratio Return per unit of total volatility	3.69	0.13	+3.56
Sortino ratio Return per unit of downside risk	5.91	0.83	+5.08
Omega ratio Gain probability vs. loss probability	1.67	1.10	+0.57
Calmar ratio Return relative to maximum drawdown	13.80	0.15	+13.65
Martin ratio Return relative to average drawdown	33.65	0.30	+33.35
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NKTR vs. PGY - Sharpe Ratio Comparison

The current NKTR Sharpe Ratio is 3.69, which is higher than the PGY Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of NKTR and PGY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NKTR	PGY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.69	0.13	+3.56
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.20	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.10	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.01	-0.26	+0.27

Correlation

The correlation between NKTR and PGY is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NKTR vs. PGY - Dividend Comparison

Neither NKTR nor PGY has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NKTR vs. PGY - Drawdown Comparison

The maximum NKTR drawdown since its inception was -99.61%, roughly equal to the maximum PGY drawdown of -98.09%. Use the drawdown chart below to compare losses from any high point for NKTR and PGY.

Drawdown Indicators

	NKTR	PGY	Difference
Max Drawdown Largest peak-to-trough decline	-99.61%	-98.09%	-1.52%
Max Drawdown (1Y) Largest decline over 1 year	-46.54%	-75.71%	+29.17%
Max Drawdown (5Y) Largest decline over 5 years	-97.93%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.61%	—	—
Current Drawdown Current decline from peak	-95.35%	-96.74%	+1.39%
Average Drawdown Average peak-to-trough decline	-68.17%	-91.80%	+23.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.09%	39.17%	-20.08%

Volatility

NKTR vs. PGY - Volatility Comparison

Nektar Therapeutics (NKTR) and Pagaya Technologies Ltd. (PGY) have volatilities of 17.64% and 17.79%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NKTR	PGY	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.64%	17.79%	-0.15%
Volatility (6M) Calculated over the trailing 6-month period	65.68%	57.75%	+7.93%
Volatility (1Y) Calculated over the trailing 1-year period	189.39%	84.56%	+104.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	121.48%	147.44%	-25.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	96.96%	147.44%	-50.48%

Financials